| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > Corporate Donations, Government Grants and the Public Relations Justification and Ethics in Giving |
|
Advice You - Corporate Donations, Government Grants and the Public Relations Justification and Ethics in Giving
So often we hear people complain that this person is rich and they did not give enough to that cause or that According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product Corporation is only giving for the Public Relations and they lack ethics. The question is should they not giv ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in if they are only doing it for selfish motivations or for a win/win scenario, which is tied to a public relat lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ons and therefore a profit motive or in the case of a government to win the hearts and minds of the people? I here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe it is a government are they only giving to help secure favorable trade deals or future allies? This has alw d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ys been a topic of conversation indeed and it recently resurfaced in an online think tank forum when someone ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc omplained about why people, governments, companies and or organizations give. But I find the debate rather ag easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi gravating as it is merely pointing fingers and looking gift horses in the mouth, which we all know is not wis nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically . In my career in my company we have helped homeless, done community fundraisers, participated in national gi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ing and gone out of our way to assist in the common good. Now mind you these are just a few of the things I ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ave been able to do thru my company in trade for a little PR to justify it to my company, team, franchisees, ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a mployees and customers, who all assisted my efforts. By being able to justify the expenditures to help the co dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod mon good in a business in trade for a little PR everyone wins. Had we not had that opportunity, it might be v cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ry hard to justify these volunteer efforts and contributions to the whole of humanity. So, to criticize the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen efforts or cash given is the wrong approach and therefore I will have to ask you to strike your comment and r t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel consider your linear thought process. And I want you to tell us all you have done to the common good and lets ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust compare. In other words which way works the best? My way, the entrepreneurial giver or your way the complaine y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products that nothing is ever right, or just or fair? Because I am into problem solving not complaining; I do not bel . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de eve a Think Tank is a place to complain, but if you have a complaint, a legitimate one, let’s fix it without elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ondemning capitalism, gift givers, corporations, NGOs, governments or World Leadership. Consider this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Customer Service Reps: Resist Kicking Your Customers Out The Door! Business Process Management Consulting
|